Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis
Trial details
- Registry ID
- NCT06850727
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative ColitisNCT06850727 | Odyssey Therapeutics | Phase 2 | Recruiting | 2026-04Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |